Genomic testing is a rapidly growing field, especially in cancer medicine, where it can be used to match patients to the most effective targeted treatment. In the past decade, we have seen rapid growth in the number of new genomic tests that are available. However, genomic testing is usually very expensive, raising the question of whether the testing is worth the cost.
Chan Shen, health policy scholar at the Baker Institute and an assistant professor in the Department of Health Services Research and the Department of Biostatistics at The University of Texas MD Anderson Cancer Center, examines the issue in "Economic perspective on genomic testing: Is it worth the cost?" published in the Baker Institute Blog on March 25, 2015.
